NNVC NANOVIRICIDES, INC.

Overview and Growth

NANOVIRICIDES, INC. generated $0.00 of revenue in fiscal 2026, with net loss of $8.22M and an operating cash outflow of $7.70M. On a per-share basis, diluted EPS was -$0.41, which connects the reported earnings outcome with the company’s diluted share count. Diluted shares averaged 20.19M; this is the reported share base over which the company’s diluted per-share earnings were spread. Diluted shares moved 33.5% from 15.12M in fiscal 2025, leaving the current share base higher year over year. Total assets stood at $9.87M, showing the scale of resources supporting revenue, earnings, liquidity, and financing.

Profitability

The reported operating result was an operating loss of $8.31M, reflecting costs that exceeded gross profit. The company ended the period with a net loss of $8.22M, extending the operating result through all remaining items. The company reported negative EBITDA of $7.79M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The company reported a pretax loss of $8.22M, before the effect of income taxes. Relative to period-end equity, the net loss represented 94.8%. Relative to total assets, the net loss represented 83.2%. The net loss narrowed to $8.22M from $9.47M in fiscal 2025.

Liquidity and Capital Structure

The company held $9.87M of assets against $1.20M of liabilities and $8.67M of equity, revealing how the asset base was financed. At period end, current assets of $3.16M compared with current liabilities of $1.19M, defining the company’s short-term resource position. At 2.66x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $2.79M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 234.7% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Book equity represented 87.8% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 12.2% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 28.3%, comparing reported cash and equivalents with the full positive asset balance. Compared with $8.82M in fiscal 2025, the current asset base moved 11.9% and finished higher. Against $7.52M of equity in fiscal 2025, the current book-equity balance moved 15.3% and ended higher. Compared with $1.56M in fiscal 2025, the current cash balance moved 79.3% and finished higher.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $7.70M, showing that operations absorbed cash during the period. The company spent $84.32K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Operating cash flow and capital spending combined to leave a $7.78M cash deficit after capital spending. Relative to total assets, the post-investment cash deficit measured 78.8%. The operating cash outflow narrowed to $7.70M from $8.48M in fiscal 2025.

Based on the annual report for the fiscal year ending Jun 30, 2026. Analysis generated Oct 21, 2026.